Tagoor Laboratories Private Limited

Tagoor Laboratories Private Limited - pharma in Andhra Pradesh, India. FY 2026 financials & compliance.
CIN U24100AP2009PTC109536 Incorporated 31 January 2009 ROC Vijayawada HQ Andhra Pradesh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2023
₹496.45 Cr
▼ 31% YoY
Net profit · FY 2023
₹14.36 Cr
Net margin 2.9%
EBITDA · FY 2023
₹51.96 Cr
EBITDA margin 10.5%
Authorised capital
₹49 Cr
Registered with MCA
Paid-up capital
₹11.85 Cr
Issued & subscribed
Open charges
₹296.98 Cr
Satisfied ₹30.25 Cr
Company age
17 yrs
Est. 2009
Employees · EPFO
1,442
Provident fund records

About Tagoor Laboratories Private Limited

Data last updated:

Tagoor Laboratories Private Limited is a private limited company based in Andhra Pradesh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 31 January 2009 and has been in existence for over 17 years.

The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24100AP2009PTC109536. Its GSTIN is 37AACCV9421B1ZH (Andhra Pradesh). The company holds 3 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹49 Cr and a paid-up capital of ₹11.85 Cr. It was formerly known as Vensub Laboratories Private Limited. It is led by directors including Kasi Viswanadharaju Pericherla (Managing Director) and Mudundi Rameshraju.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Sy No.29 Tupakulagudem Pochavaram Panchayat, Andhra Pradesh, India – 534341.

As per the financials filed for FY 2023, the company reported a revenue of ₹496.45 Cr, a decline of 31% compared to the previous year. For the same year it recorded a net profit of ₹14.36 Cr (net margin 2.9%) and EBITDA of ₹51.96 Cr (EBITDA margin 10.5%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years and 850% over five years.

The company has about 1,442 employees on its provident fund (EPFO) records.

The company is associated with 2 brands: Angels Pharma and Tagoor. As per MCA filings, the company has open charges of ₹296.98 Cr and satisfied charges of ₹30.25 Cr on record. Court records list 44 cases involving the company, including 37 filed by the company and 7 filed against it; 23 cases are pending. The company has 5 deals on record (3 secondary share transfers, 2 rights issues); the latest was in February 2020. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Symed Labs Limited with revenue of ₹791.92 Cr.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tagoorlabs.com.

Company details

CIN U24100AP2009PTC109536
Registration Number 109536
Incorporation Date 31 January 2009
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant

CIN history

Tagoor Laboratories has one previous CIN (Corporate Identification Number): U24100TG2009PTC062671. The current CIN is U24100AP2009PTC109536, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24100AP2009PTC109536Current
U24100TG2009PTC062671Previous

Contact details

Tagoor Laboratories Private Limited's registered office is in Andhra Pradesh. Its website is tagoorlabs.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Sy No.29 Tupakulagudem Pochavaram Panchayat, Andhra Pradesh, India – 534341
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Tagoor Laboratories Private Limited, buy the company report.

Comprehensive company report
Tagoor Laboratories Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Tagoor Laboratories operates two associated brands: Angels Pharma and TAGOOR. Each brand links to its own profile.

BrandDescriptionWebsite
Operates as an integrated manufacturer of pharmaceutical APIs and intermediates.angelspharma.com
Manufactures APIs, intermediates, and provides CDMO services for pharmaceuticals.tagoorlabs.com

Business activity

The main business activity of Tagoor Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Tagoor Laboratories Private Limited, buy the company report.

Financials of Tagoor Laboratories Private Limited

FY 2024 filings available

Tagoor Laboratories Private Limited reported revenue of ₹496.45 Cr (down 31% YoY) for FY 2023.

Revenue · FY 2023
₹496.45 Cr ▼ 31%
Net profit · FY 2023
₹14.36 Cr margin 2.9%
EBITDA · FY 2023
₹51.96 Cr margin 10.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 31%
3 years · compounded
▲ 35%
5 years · compounded
▲ 850%
EBITDA CAGR growth
1 year
▼ 67%
3 years · compounded
▲ 53%

Revenue fell 31% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 850%. EBITDA fell 67% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹496.45 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹51.96 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹14.36 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin10.5%
Net Profit Margin2.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Tagoor Laboratories Private Limited, buy the company report.

Board of directors of Tagoor Laboratories Private Limited

Tagoor Laboratories has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Mudundi RameshrajuDirector31 Jan 200917 Years 8 MonthsCurrent
Penmetsa Achyuta RamarajuDirector31 Jan 200917 Years 8 MonthsCurrent
Venkata Subramanyam Raju PenmetsaDirector16 Aug 20179 Years 2 MonthsCurrent
Kasi Viswanadharaju PericherlaManaging Director16 Aug 20179 Years 2 MonthsCurrent

Peer comparison

Tagoor Laboratories Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Symed Labs Limited₹791.92 Cr (FY 2025)6.0%Hyderabad, Telangana, India
Sterile India Private Limited₹791.14 Cr (FY 2025)-13.0%New Delhi, Delhi, India
SMS Pharmaceuticals Limited₹788.97 Cr (FY 2025)11.0%Hyderabad, Telangana, India
Symbiotec Pharmalab Limited₹755.98 Cr (FY 2025)5.0%Mhow, Madhya Pradesh, India
Optimus Drugs Private Limited₹713.55 Cr (FY 2024)-41.0%Hyderabad, Telangana, India
Supriya Lifescience Limited₹706.3 Cr (FY 2025)22.0%Mumbai, Maharashtra, India
Dasami Lab Private Limited₹694.39 Cr (FY 2025)22.0%Chityal, Telangana, India
Anuh Pharma Limited₹670.97 Cr (FY 2025)2.0%Mumbai, Maharashtra, India
Tagoor Laboratories Private Limitedthis company₹496.45 Cr (FY 2023)₹14.36 Cr2.9%-31.0%1,442Andhra Pradesh, India

To see the full peer comparison of Tagoor Laboratories Private Limited, buy the company report.

Auditor

Tagoor Laboratories Private Limited is audited by G L N PRASAD & Co LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
G L N PRASAD & Co LLPFY 2023015176S/S200067

Shareholding

The shareholding of Tagoor Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Tagoor Laboratories Private Limited, buy the company report.

Charges & borrowings

Open charges
₹296.98 Cr
Satisfied charges
₹30.25 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹127.21 Cr
State Bank of India₹90.20 Cr
Others₹79.57 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
17 Sep 2025101169785Others₹40 CrOpen
15 Sep 2025101168361Others₹89.74 LakhOpen
28 Mar 2025101079882Others₹3.81 CrOpen
29 Feb 2024100913334State Bank of India₹28 LakhOpen
07 Feb 2024100891547Others₹4.86 CrOpen

To see the full charge records of Tagoor Laboratories Private Limited, buy the company report.

Total charge records: 20 View all charges

Deals & funding

Tagoor Laboratories Private Limited has 5 deals on record (3 secondary share transfers, 2 rights issues); the latest was in February 2020.

Total deals
5
Secondary share transfers
3
Rights issues
2

Deals on record (5 of 5)

WhenDealAmountParties
Feb 2020Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Jan 2020Rights issue₹8.3 LakhInvestors: 4 individuals
Jan 2019Secondary share transferUndisclosedBuyer: 4 individuals
Seller: 3 individuals
Mar 2018Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2018Rights issue₹9.95 CrInvestors: 4 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Tagoor Laboratories Private Limited was last rated by Indiarating on 08 Jan 2021.

Rating agencyRated onRating
Indiarating08 Jan 2021

To see the full credit ratings and regulatory alerts of Tagoor Laboratories Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Tagoor Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Tagoor Laboratories Private Limited has a workforce of 1,442 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.

Employee count
1,442
Active EPFO establishments
1
Employee growth
136.39%

GST

Tagoor Laboratories has 3 GST registrations: 2 active and 1 cancelled or inactive.

Total GSTINs
3
Active
2
Cancelled / inactive
1
GSTINStateStatusRegistered on
37AACCV9421B1ZHAndhra PradeshActive21 Sep 2017
36AACCV9421B1ZJTelanganaActive07 Oct 2024

To see the full GST registrations and return filing status of Tagoor Laboratories Private Limited, buy the company report.

Recent activity

Tagoor Laboratories Private Limited has 7 board changes on record since 2009: 4 appointments and 3 cessations. The latest: Buchipudi Reddy Sambasiva ceased to be Additional Director on 29 Dec 2022.

Charges
A charge with Others amounted to Rs. 40.00 Cr with Charge ID 101169785 was registered on 17 Sep 2025.
Charges
A charge with Others amounted to Rs. 0.90 Cr with Charge ID 101168361 was registered on 15 Sep 2025.
Charges
A charge with Others amounted to Rs. 3.81 Cr with Charge ID 101079882 was registered on 28 Mar 2025.
Charges
A charge with Others of Rs. 30.00 Cr registered on 29 Apr 2021 with Charge ID 100443845 was modified on 10 Jan 2025.
AGM
Tagoor Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Tagoor Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada.
Charges
A charge with State Bank Of India amounted to Rs. 0.28 Cr with Charge ID 100913334 was registered on 29 Feb 2024.
Charges
A charge with State Bank Of India of Rs. 89.53 Cr registered on 30 Nov 2018 with Charge ID 100228093 was modified on 22 Feb 2024.
Charges
A charge with Others amounted to Rs. 4.86 Cr with Charge ID 100891547 was registered on 07 Feb 2024.
Charges
A charge with Hdfc Bank Limited of Rs. 125.40 Cr registered on 26 Apr 2021 with Charge ID 100442295 was modified on 27 Jul 2023.
Charges
A charge with State Bank Of India amounted to Rs. 0.39 Cr with Charge ID 100694545 was registered on 24 Jan 2023.
Ceased
Buchipudi Reddy Sambasiva ceased to be Additional Director.

29 earlier events are in the company report.

Frequently asked questions

Tagoor Laboratories is an active private limited company based in Andhra Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 31 January 2009 (17+ years old) and is registered under CIN U24100AP2009PTC109536.

Tagoor Laboratories has 4 current directors:

The latest financial statements of Tagoor Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Tagoor Laboratories is 37AACCV9421B1ZH, registered in Andhra Pradesh. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 36AACCV9421B1ZJ (Telangana).

The CIN (Corporate Identification Number) of Tagoor Laboratories is U24100AP2009PTC109536. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Tagoor Laboratories has 44 court cases on record: 37 filed by the company and 7 filed against it. 23 are pending. Most are in the district courts.

Tagoor Laboratories was incorporated on 31 January 2009, making it 17+ years old. It is registered with the Registrar of Companies, Vijayawada.

Tagoor Laboratories has 5 deals on record (3 secondary share transfers, 2 rights issues); the latest was in February 2020.

The peers of Tagoor Laboratories by revenue are Symed Labs Limited, Sterile India Private Limited, SMS Pharmaceuticals Limited, Symbiotec Pharmalab Limited, Optimus Drugs Private Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Buchipudi Reddy Sambasiva ceased to be Additional Director on 29 Dec 2022. Alluri Rama Raju ceased to be Director on 14 May 2018. Kasi Viswanadharaju Pericherla was appointed as Managing Director on 16 Aug 2017. Tagoor Laboratories has 7 board changes on record in total.

Tagoor Laboratories can be reached through the website tagoorlabs.com. Its registered office is in Andhra Pradesh, India.